|
Volumn 12, Issue 2, 2002, Pages 90-96
|
Premalignant vulval disorders
|
Author keywords
HPV; Premalignant; VIN; Vulva
|
Indexed keywords
ALPHA INTERFERON;
FLUOROURACIL;
IMIQUIMOD;
TUMOR NECROSIS FACTOR ALPHA;
VIRUS VACCINE;
AGE;
ANTIVIRAL ACTIVITY;
BIOPSY TECHNIQUE;
CANCER GROWTH;
CANCER INVASION;
CANCER RECURRENCE;
CANCER RISK;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
DISEASE EXACERBATION;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN PAPILLOMAVIRUS TYPE 16;
HUMAN PAPILLOMAVIRUS TYPE 18;
HUMAN PAPILLOMAVIRUS TYPE 33;
HUMAN PAPILLOMAVIRUS TYPE 39;
IMMUNIZATION;
INCIDENCE;
INFECTION RISK;
LONG TERM CARE;
PATIENT ATTITUDE;
PHOTODYNAMIC THERAPY;
PRECANCER;
RISK ASSESSMENT;
SMOKING;
SYMPTOMATOLOGY;
UTERINE CERVIX CARCINOMA IN SITU;
VIRUS TYPING;
VULVA DISEASE;
VULVA PRURITUS;
VULVODYNIA;
WART VIRUS;
|
EID: 0036204012
PISSN: 09575847
EISSN: None
Source Type: Journal
DOI: 10.1054/cuog.2001.0240 Document Type: Conference Paper |
Times cited : (6)
|
References (15)
|